Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0328 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0261 | 0.7477 | 0.7477 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0328 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0112 | 0.1803 | 0.1803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0328 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.028 | 0.8197 | 0.8197 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0244 | 0.684 | 0.684 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0071 | 0.0266 | 0.0266 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0121 | 0.2136 | 0.2136 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0261 | 0.7477 | 0.7477 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0195 | 0.4963 | 0.4963 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0178 | 0.4316 | 0.4316 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0261 | 0.7487 | 0.7487 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0089 | 0.0951 | 0.0951 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0112 | 0.1803 | 0.1803 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0328 | 1 | 1 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0328 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase 1, putative | 0.0097 | 0.1229 | 0.1229 |
Echinococcus multilocularis | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.0085 | 0.0803 | 0.0803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0178 | 0.4316 | 0.4316 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.0266 | 0.0266 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0261 | 0.7477 | 0.7477 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0121 | 0.2136 | 0.2136 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0261 | 0.7477 | 0.7477 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0112 | 0.1803 | 0.1803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0112 | 0.1803 | 0.1803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0244 | 0.684 | 0.684 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0112 | 0.1803 | 0.1803 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0138 | 0.279 | 0.279 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0112 | 0.1803 | 0.1803 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0328 | 1 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0085 | 0.0803 | 0.0803 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0328 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0178 | 0.4327 | 0.4327 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0121 | 0.2136 | 0.2136 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0178 | 0.4327 | 0.4327 |
Trichomonas vaginalis | phopsphatidylinositol 3-kinase, drosophila, putative | 0.0121 | 0.2136 | 0.2136 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.0069 | 0.0069 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0112 | 0.1803 | 0.1803 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.01 | 0.1363 | 0.1363 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0112 | 0.1803 | 0.1803 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0328 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0178 | 0.4316 | 0.4316 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0328 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0112 | 0.1803 | 0.1803 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0121 | 0.2136 | 0.2136 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0328 | 1 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0112 | 0.1803 | 0.1803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0261 | 0.7477 | 0.7477 |
Echinococcus granulosus | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.0085 | 0.0803 | 0.0803 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0328 | 1 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0244 | 0.684 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0156 | 0.35 | 0.35 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0197 | 0.5037 | 0.5037 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0089 | 0.0951 | 0.0951 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0178 | 0.4327 | 0.4327 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0197 | 0.5037 | 0.5037 |
Entamoeba histolytica | hypothetical protein | 0.01 | 0.1363 | 0.1363 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0197 | 0.5037 | 0.5037 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0261 | 0.7487 | 0.7487 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.009 | 0.0976 | 0.0976 |
Echinococcus granulosus | phosphatidylinositol 45 bisphosphate 3 kinase | 0.0208 | 0.547 | 0.547 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0328 | 1 | 1 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0071 | 0.0266 | 0.039 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0112 | 0.1803 | 0.1803 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0112 | 0.1803 | 0.1803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0221 | 0.594 | 0.594 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.0803 | 0.0803 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0188 | 0.4697 | 0.4697 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0244 | 0.684 | 0.684 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0178 | 0.4327 | 0.4327 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0244 | 0.684 | 0.684 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0214 | 0.5673 | 0.5673 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0328 | 1 | 1 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0328 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0244 | 0.684 | 0.684 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0261 | 0.7487 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0244 | 0.684 | 0.684 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0065 | 0.003 | 0.003 |
Brugia malayi | phosphoinositide 3'-hydroxykinase p110-alpha subunit, putative | 0.0088 | 0.0889 | 0.0889 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0121 | 0.2136 | 0.2136 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0208 | 0.547 | 0.547 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0244 | 0.684 | 0.684 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0328 | 1 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0112 | 0.1803 | 0.1803 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.0208 | 0.547 | 0.547 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0195 | 0.4963 | 0.4963 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit gamma, putative | 0.0121 | 0.2136 | 0.2136 |
Giardia lamblia | GTOR | 0.0328 | 1 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0112 | 0.1803 | 0.1803 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.